Clear Street initiates REalloys stock with buy rating on rare earth potential

Clear Street initiated coverage of REalloys (NASDAQ:ALOY) with a Buy and $35 price target vs the current $7.99 share price, implying substantial upside; the analyst uses an 11x EV/EBITDA on a 2030 EBITDA estimate of $265M and assumes ~15M shares (≈25%) potential dilution. REalloys completed a $50M equity offering (2,702,702 shares at $18.50, plus a 396,963-share option), is building a ~$40M heavy rare earth metallization facility in Ohio targeting early–mid 2027 start and annual output of ~30 tonnes dysprosium and ~15 tonnes terbium, and signed an MOU for up to 10% offtake from Sheep Creek. Key risks include planned dilution to fund capex and execution of multi-phase expansion required to reach the projected 7% global market share by 2030.

Analysis

Vertical integration into heavy-rare-earth metallization and magnet production would, if executed, shift value capture from raw concentrate suppliers toward mid/downstream players — that second-order shift pressures commodity-focused peers to either move downstream or accept lower margins. U.S. industrial policy tailwinds raise the probability of non-dilutive support, but conditionality and timing mean grant outcomes are binary catalysts rather than steady cash flows; expect share-price re-rates to cluster around discrete financing, permitting, and commissioning events.

Scale-up risk is the dominant single variable. Metallurgical processes that look clean and reproducible at lab or pilot scale often reveal throughput, reagent recovery, and impurity-sensitivity issues at commercial scale that can blow out both capex and opex by 30–100%. Given the tiny global tonnages of key heavy rare earths, a few tonnes of underperformance or a one-quarter production delay can swing annual revenues by multiples, making short-term earnings highly path-dependent.

Market expectations embedded in sell-side projections appear concentrated on upside scenarios with limited downside modeling. That creates fertile ground for option-structured bets and event-driven trades tied to clear milestones (financing closes, plant commissioning, first commercial offtake). On a 12–36 month horizon, the most credible re-rating catalysts are proof-of-commercial output and firm long-term offtake contracts with creditworthy counterparties; absent those, downside to current valuation is asymmetric due to equity-funded dilution risk and execution uncertainty.

Key Decisions for Investors

• Tactical long with defined downside: Buy ALOY Jan 2029 10/25 call spread (debit) size to represent 0.5–1.0% of portfolio. Rationale: asymmetric upside if commercial output proves repeatable; capped premium limits dilution and scale-up binary risk. Target: 3x+ payoff if commissioning and first commercial offtake announced within 18 months; max loss = premium.
• Event-driven equity exposure: Initiate a small long ALOY position sized to 1–2% of liquid capital ahead of the next major construction milestone, hedge with a 30% OTM put for 12 months. Rationale: protects against execution delays while retaining upside to grants/contract news. Take-profit if stock rises 50% post-milestone; cut if milestone missed or permit revoked.
• Pair trade to neutralize macro metal-price moves: Long MP Materials (MP) or Lynas (LYC) equal-dollar vs short ALOY (2:1 notional depending on beta) over 12–24 months. Rationale: rewards incumbents if new entrant execution fails while limiting exposure to industry-wide rare-earth price shocks. Target: capture relative alpha of 20–40%; stop-loss at 15% on pair basis.
• Short speculative premium: If equity prints a financing at materially better terms than secondary market sentiment implies, consider selling short-dated covered calls or buying puts to capitalize on post-offering weakness. Rationale: equity-financed dilution events often produce 15–30% downward repricing in absence of commensurate operational progress. Time horizon: 1–3 months around financing announcements.